National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1113816

History of Changes from the VAERS Wayback Machine

First Appeared on 7/2/2021

VAERS ID: 1113816
VAERS Form:2
Age:88.0
Sex:Male
Location:Foreign
Vaccinated:2021-02-15
Onset:2021-02-01
Submitted:0000-00-00
Entered:2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / -

Administered by: Other      Purchased by: ??
Symptoms: Pneumonitis, Pyrexia, Respiratory rate decreased

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-02-01
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cardiac failure; COVID-19; Unspecified disease of respiratory system
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': IEPFIZER INC2021250326

Write-up: SEVERE PNEUMONITIS; VERY HIGH TEMPERATURE; LOW RESPIRATORY RATE; This is a spontaneous report from received from a contactable physician via regulatory authority (RA) downloaded from the Agency Regulatory Authority-WEB IE-HPRA-2021-066942. An 88-year-old male patient received the second dose of BNT162B2 (COMIRNATY, lot number unknown), on 15Feb2021 (at the age of 88-year-old) at single dose for COVID-19 immunisation. The patient''s medical history included cardiac failure, unspecified disease of respiratory system and COVID-19 on Mar2020. The patient''s concomitant medications included various medicines (unspecified). The patient previously received the first dose of BNT162B2 (COMIRNATY, lot number unknown), on approximately 18Jan2021 at single dose for COVID-19 immunisation. In Feb2021, hours post vaccination, the patient experienced a very high temperature, low respiratory rate and severe pneumonitis. The patient was administered oxygen, midazolam and BUSCOPAN. The events were reported as serious with seriousness criteria death. In Feb2021, the patient died after experiencing pyrexia, respiratory rate decreased and pneumonitis following vaccination with COMIRNATY for COVID-19 immunisation. It was unknown if autopsy was performed. The outcome of the events was fatal. No follow up attempts are possible; information about batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: SEVERE PNEUMONITIS; LOW RESPIRATORY RATE; VERY HIGH TEMPERATURE

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1113816&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166